GlassScriptPhysician profile
David A Ruedrich
NPI 1083725089
$1,329.75
in general payments reported to CMS, 2019-2025
27 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $78.61 · 2020: $137 · 2021: $602 · 2022: $254 · 2023: $259.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $259.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $258.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $286.56 | 2019-2023 | Ubrelvy, Qulipta, Orilissa |
| Hologic Sales and Service, LLC | $118.78 | 2020-2021 | |
| Myriad Women'S Health, INC. | $115.50 | 2023 | Myrisk |
| Mayne Pharma Commercial LLC | $111.39 | 2021-2023 | |
| Agile Therapeutics, INC. | $85.25 | 2021 | |
| Minerva Surgical, INC | $80.43 | 2021-2022 | |
| Myovant Sciences INC. | $66.85 | 2021 | |
| Evofem Biosciences, INC. | $56.70 | 2021 | |
| Pfizer INC. | $42.30 | 2019-2020 | |
| Aspira Women'S Health INC | $35.84 | 2021-2022 | |
| Therapeuticsmd, INC. | $29.76 | 2019-2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $27.86 | 2022 | |
| Daiichi Sankyo INC. | $26.27 | 2021 | |
| Avion Pharmaceuticals | $24.41 | 2019-2021 | |
| Exeltis, USA INC. | $24.23 | 2019-2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Pharmaceuticals INC. | $24.11 | 2021 | |
| Alydia Health | $23.89 | 2021 | |
| Coopersurgical, INC. | $22.75 | 2021 | |
| Allergan, INC. | $18.99 | 2020 | |
| Ibsa Pharma INC. | $15.90 | 2023 | Tirosint, Licart |
| Merck Sharp & Dohme LLC | $15.72 | 2021 | |
| Shield Therapeutics INC | $14.36 | 2023 | Accrufer |
| Scynexis, INC. | $14.08 | 2022 | |
| Amag Pharmaceuticals, INC. | $13.81 | 2020 | |
| Medtronic, INC. | $11.76 | 2022 | |
| Organon LLC | $11.40 | 2021 | |
| Meditrina | $10.85 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Ruedrich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.